HYP-1, a novel diamide compound, relieves inflammatory and neuropathic pain in rats

Yoo Lim Kam, Seung Keun Back, Bohee Kang, Young Yun Kim, Hwa Jung Kim, Hyewhon Rhim, Seung Yeol Nah, Jun Mo Chung, Dong Hyun Kim, Jin Sung Choi, Heung Sik Na, Hea Young Park Choo

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

In the present study, we investigated whether a novel compound, 2-(2-(4-((4-chlorophenyl)(phenyl)methyl)piperazin-1-yl)-2-oxoethylamino)-N-(3,4, 5-trimethoxybenzyl)acetamide (HYP-1), is capable of binding to voltage-gated sodium channels (VGSCs) and evaluated both its inhibitory effect on Na + currents of the rat dorsal root ganglia (DRG) sensory neuron and its in vivo analgesic activity using rat models of inflammatory and neuropathic pain. HYP-1 showed not only high affinity for rat sodium channel (site 2), but also potent inhibitory activity against the TTX-R Na+ currents of the rat DRG sensory neuron. HYP-1 co-injected with formalin (5%, 50 μl) under the plantar surface of rat hind paw dose-dependently reduced spontaneous pain behaviors during both the early and late phases. This result was confirmed by c-Fos immunofluorescence in the L4-5 spinal segments. A large number of c-Fos-positive neurons were observed in rat injected with a mixture of formalin and vehicle, but not in rat treated with a mixture of formalin and HYP-1. In addition, the effectiveness of HYP-1 (6 and 60 mg/kg, i.p.) in suppression of neuropathic pain, such as mechanical, cold and warm allodynia, induced by rat tail nerve injury was investigated. HYP-1 showed limited selectivity over hERG, N-type and T-type channels. Our present results indicate that HYP-1, as a VGSC blocker, has potential analgesic activities against nociceptive, inflammatory and neuropathic pain.

Original languageEnglish
Pages (from-to)33-42
Number of pages10
JournalPharmacology Biochemistry and Behavior
Volume103
Issue number1
DOIs
Publication statusPublished - 2012 Nov 1

Fingerprint

Diamide
Neuralgia
Rats
Formaldehyde
Neurons
Spinal Ganglia
Sensory Receptor Cells
Voltage-Gated Sodium Channel Blockers
Analgesics
Voltage-Gated Sodium Channels
Nociceptive Pain
Sodium Channels
Hyperalgesia
Fluorescent Antibody Technique
Tail
Pain

Keywords

  • c-Fos
  • Formalin test
  • Inflammatory pain
  • Neuropathic pain
  • Nociception
  • Sodium channel

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Pharmacology
  • Toxicology
  • Behavioral Neuroscience
  • Biological Psychiatry

Cite this

Kam, Y. L., Back, S. K., Kang, B., Kim, Y. Y., Kim, H. J., Rhim, H., ... Choo, H. Y. P. (2012). HYP-1, a novel diamide compound, relieves inflammatory and neuropathic pain in rats. Pharmacology Biochemistry and Behavior, 103(1), 33-42. https://doi.org/10.1016/j.pbb.2012.07.010

HYP-1, a novel diamide compound, relieves inflammatory and neuropathic pain in rats. / Kam, Yoo Lim; Back, Seung Keun; Kang, Bohee; Kim, Young Yun; Kim, Hwa Jung; Rhim, Hyewhon; Nah, Seung Yeol; Chung, Jun Mo; Kim, Dong Hyun; Choi, Jin Sung; Na, Heung Sik; Choo, Hea Young Park.

In: Pharmacology Biochemistry and Behavior, Vol. 103, No. 1, 01.11.2012, p. 33-42.

Research output: Contribution to journalArticle

Kam, YL, Back, SK, Kang, B, Kim, YY, Kim, HJ, Rhim, H, Nah, SY, Chung, JM, Kim, DH, Choi, JS, Na, HS & Choo, HYP 2012, 'HYP-1, a novel diamide compound, relieves inflammatory and neuropathic pain in rats', Pharmacology Biochemistry and Behavior, vol. 103, no. 1, pp. 33-42. https://doi.org/10.1016/j.pbb.2012.07.010
Kam, Yoo Lim ; Back, Seung Keun ; Kang, Bohee ; Kim, Young Yun ; Kim, Hwa Jung ; Rhim, Hyewhon ; Nah, Seung Yeol ; Chung, Jun Mo ; Kim, Dong Hyun ; Choi, Jin Sung ; Na, Heung Sik ; Choo, Hea Young Park. / HYP-1, a novel diamide compound, relieves inflammatory and neuropathic pain in rats. In: Pharmacology Biochemistry and Behavior. 2012 ; Vol. 103, No. 1. pp. 33-42.
@article{91730c80982644ec941a9c2b160d1f0a,
title = "HYP-1, a novel diamide compound, relieves inflammatory and neuropathic pain in rats",
abstract = "In the present study, we investigated whether a novel compound, 2-(2-(4-((4-chlorophenyl)(phenyl)methyl)piperazin-1-yl)-2-oxoethylamino)-N-(3,4, 5-trimethoxybenzyl)acetamide (HYP-1), is capable of binding to voltage-gated sodium channels (VGSCs) and evaluated both its inhibitory effect on Na + currents of the rat dorsal root ganglia (DRG) sensory neuron and its in vivo analgesic activity using rat models of inflammatory and neuropathic pain. HYP-1 showed not only high affinity for rat sodium channel (site 2), but also potent inhibitory activity against the TTX-R Na+ currents of the rat DRG sensory neuron. HYP-1 co-injected with formalin (5{\%}, 50 μl) under the plantar surface of rat hind paw dose-dependently reduced spontaneous pain behaviors during both the early and late phases. This result was confirmed by c-Fos immunofluorescence in the L4-5 spinal segments. A large number of c-Fos-positive neurons were observed in rat injected with a mixture of formalin and vehicle, but not in rat treated with a mixture of formalin and HYP-1. In addition, the effectiveness of HYP-1 (6 and 60 mg/kg, i.p.) in suppression of neuropathic pain, such as mechanical, cold and warm allodynia, induced by rat tail nerve injury was investigated. HYP-1 showed limited selectivity over hERG, N-type and T-type channels. Our present results indicate that HYP-1, as a VGSC blocker, has potential analgesic activities against nociceptive, inflammatory and neuropathic pain.",
keywords = "c-Fos, Formalin test, Inflammatory pain, Neuropathic pain, Nociception, Sodium channel",
author = "Kam, {Yoo Lim} and Back, {Seung Keun} and Bohee Kang and Kim, {Young Yun} and Kim, {Hwa Jung} and Hyewhon Rhim and Nah, {Seung Yeol} and Chung, {Jun Mo} and Kim, {Dong Hyun} and Choi, {Jin Sung} and Na, {Heung Sik} and Choo, {Hea Young Park}",
year = "2012",
month = "11",
day = "1",
doi = "10.1016/j.pbb.2012.07.010",
language = "English",
volume = "103",
pages = "33--42",
journal = "Pharmacology Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - HYP-1, a novel diamide compound, relieves inflammatory and neuropathic pain in rats

AU - Kam, Yoo Lim

AU - Back, Seung Keun

AU - Kang, Bohee

AU - Kim, Young Yun

AU - Kim, Hwa Jung

AU - Rhim, Hyewhon

AU - Nah, Seung Yeol

AU - Chung, Jun Mo

AU - Kim, Dong Hyun

AU - Choi, Jin Sung

AU - Na, Heung Sik

AU - Choo, Hea Young Park

PY - 2012/11/1

Y1 - 2012/11/1

N2 - In the present study, we investigated whether a novel compound, 2-(2-(4-((4-chlorophenyl)(phenyl)methyl)piperazin-1-yl)-2-oxoethylamino)-N-(3,4, 5-trimethoxybenzyl)acetamide (HYP-1), is capable of binding to voltage-gated sodium channels (VGSCs) and evaluated both its inhibitory effect on Na + currents of the rat dorsal root ganglia (DRG) sensory neuron and its in vivo analgesic activity using rat models of inflammatory and neuropathic pain. HYP-1 showed not only high affinity for rat sodium channel (site 2), but also potent inhibitory activity against the TTX-R Na+ currents of the rat DRG sensory neuron. HYP-1 co-injected with formalin (5%, 50 μl) under the plantar surface of rat hind paw dose-dependently reduced spontaneous pain behaviors during both the early and late phases. This result was confirmed by c-Fos immunofluorescence in the L4-5 spinal segments. A large number of c-Fos-positive neurons were observed in rat injected with a mixture of formalin and vehicle, but not in rat treated with a mixture of formalin and HYP-1. In addition, the effectiveness of HYP-1 (6 and 60 mg/kg, i.p.) in suppression of neuropathic pain, such as mechanical, cold and warm allodynia, induced by rat tail nerve injury was investigated. HYP-1 showed limited selectivity over hERG, N-type and T-type channels. Our present results indicate that HYP-1, as a VGSC blocker, has potential analgesic activities against nociceptive, inflammatory and neuropathic pain.

AB - In the present study, we investigated whether a novel compound, 2-(2-(4-((4-chlorophenyl)(phenyl)methyl)piperazin-1-yl)-2-oxoethylamino)-N-(3,4, 5-trimethoxybenzyl)acetamide (HYP-1), is capable of binding to voltage-gated sodium channels (VGSCs) and evaluated both its inhibitory effect on Na + currents of the rat dorsal root ganglia (DRG) sensory neuron and its in vivo analgesic activity using rat models of inflammatory and neuropathic pain. HYP-1 showed not only high affinity for rat sodium channel (site 2), but also potent inhibitory activity against the TTX-R Na+ currents of the rat DRG sensory neuron. HYP-1 co-injected with formalin (5%, 50 μl) under the plantar surface of rat hind paw dose-dependently reduced spontaneous pain behaviors during both the early and late phases. This result was confirmed by c-Fos immunofluorescence in the L4-5 spinal segments. A large number of c-Fos-positive neurons were observed in rat injected with a mixture of formalin and vehicle, but not in rat treated with a mixture of formalin and HYP-1. In addition, the effectiveness of HYP-1 (6 and 60 mg/kg, i.p.) in suppression of neuropathic pain, such as mechanical, cold and warm allodynia, induced by rat tail nerve injury was investigated. HYP-1 showed limited selectivity over hERG, N-type and T-type channels. Our present results indicate that HYP-1, as a VGSC blocker, has potential analgesic activities against nociceptive, inflammatory and neuropathic pain.

KW - c-Fos

KW - Formalin test

KW - Inflammatory pain

KW - Neuropathic pain

KW - Nociception

KW - Sodium channel

UR - http://www.scopus.com/inward/record.url?scp=84865311962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865311962&partnerID=8YFLogxK

U2 - 10.1016/j.pbb.2012.07.010

DO - 10.1016/j.pbb.2012.07.010

M3 - Article

VL - 103

SP - 33

EP - 42

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

SN - 0091-3057

IS - 1

ER -